Anti-tumor Efficacy in Murine Models
Pymaceuticals Inc. is a burgeoning pharmaceutical company based out of San Diego, CA. Pymaceuticals specializes in monoclonal antibody fusion technology with anti-cancer indications. In recent multi-arm pre-clinical study, we have screened potential treatments to squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.
On this site, our Chief Data Analyst displays and explains the results from the most recent animal study. In this study, 250 mice were treated through a variety of drug regimes over the course of 45 days. Their physiological responses were then monitored over the course of that time. The data was analyzed and visualized using Python libraries including Pandas, NumPy, and Matplotlib. Browse the site and read the outcome comparison four treatments (Capomulin, Infubinol, Ketapril, and Placebo).
